Cargando…
Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan
There is growing interest in the utilization of real‐world data (RWD) and real‐world evidence (RWE) for regulatory purposes. However, there are challenges in the practical utilization of RWD to provide RWE as a basis for regulatory decision making. This article presents the regulatory initiatives in...
Autores principales: | Nishioka, Kinue, Makimura, Tomomi, Ishiguro, Akihiro, Nonaka, Takahiro, Yamaguchi, Mitsune, Uyama, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290512/ https://www.ncbi.nlm.nih.gov/pubmed/34528701 http://dx.doi.org/10.1002/cpt.2410 |
Ejemplares similares
-
Real world evidence (RWE) - Are we (RWE) ready?
por: Suvarna, Viraj Ramesh
Publicado: (2018) -
STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies
por: Wang, Shirley V, et al.
Publicado: (2021) -
Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
por: Maison, Patrick, et al.
Publicado: (2022) -
Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET(®) Medical Information Database Network in Japan
por: Hasegawa, Tomoaki, et al.
Publicado: (2022) -
CHALLENGES RELATED TO DATA SOURCES FOR RWE IN AGING RESEARCH
por: Lu, Kevin
Publicado: (2022)